Flora Growth (NASDAQ: FLGC), a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with more than 20,000 points of distribution, has entered into a definitive agreement to acquire Australian Vaporizers Pty Limited. The agreement outlines FLGC’s intent to acquire all issued and outstanding shares of Australian Vaporizers in exchange for 600,676 Flora common shares, which were valued at $1.7 million based on the Sept. 15, 2023, closing price of Flora’s common shares. Australian Vaporizers is one of the largest online retailers of vaporizers, hardware and accessories in Australia. According to the announcement, the deal is expected to close sometime during Q4 2023 and will be immediately accretive to Flora; the company anticipates seeing annual contributions of approximately $5.2 million in revenues, $1.2 million in gross margins and $0.5 million in net income. Those numbers are based on Australian Vaporizer’s most recently completed six-month period, which ended May 31, 2023. At that time, the company reported $2.5 million in revenues, $0.6 million gross margins and $0.25 million in net income. When the transaction is complete, Australian Vaporizers is expected to have at least $0.3 million cash on hand, inventories valued at $0.8 million and working capital of $1.1 million. “In addition to quickly improving the company’s bottom line, Australian Vaporizers has the potential to drive synergies with Flora’s existing portfolio of brands, including selling Vessel brand products in Australia, which is Flora’s fastest-growing segment,” said Flora Growth CEO Clifford Starke in the press release. “I am intimately familiar with Australian Vaporizers’ solid track record from my tenure as a board member of Namaste Technologies. The Australian market has demonstrated impressive growth, and the acquisition of Australian Vaporizers would allow Flora to be at its forefront.”

To view the full press release, visit https://ibn.fm/FJvJA

About Flora Growth Corp.

Flora Growth is a global consumer-packaged goods leader and pharmaceutical distributor serving all 50 states and 28 countries with 20,000-plus points of distribution around the world. For more information about the company, please visit www.FloraGrowth.com.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at https://ibn.fm/FLGC

About InvestorWire

InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer

InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com

InvestorWire is powered by IBN